PetMed Express, Inc. (PETS) is a publicly traded Healthcare sector company. As of May 20, 2026, PETS trades at $2.17 with a market cap of $48.15M and a P/E ratio of -0.71. PETS moved +0.00% today. Year to date, PETS is -32.22%; over the trailing twelve months it is -44.53%. Its 52-week range spans $1.57 to $6.85. Rallies surfaces PETS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in PETS news today?
PetMeds to Launch White-Label Pharmacy in 150 Rural King Stores Nationwide: PetMeds has entered a strategic partnership with Rural King to roll out a white-label pet pharmacy across 150 Rural King stores and digital platforms, leveraging its pharmacy infrastructure and licensed pharmacists. The collaboration extends PetMeds’ direct-to-consumer reach into underserved rural markets, increasing potential customer base by millions.
Silvercape Investments Ltd bought 101.00K (~$320.17K) on Aug 13, 2025.
Silvercape Investments Ltd bought 118.20K (~$379.42K) on Aug 1, 2025.
NINA CAPITAL HOLDINGS INC. bought 25.00K (~$87.42K) on Jul 21, 2025.
PETS Analyst Consensus
PETS analyst coverage data. Average price target: $0.00.
Common questions about PETS
What changed in PETS news today?
PetMeds to Launch White-Label Pharmacy in 150 Rural King Stores Nationwide: PetMeds has entered a strategic partnership with Rural King to roll out a white-label pet pharmacy across 150 Rural King stores and digital platforms, leveraging its pharmacy infrastructure and licensed pharmacists. The collaboration extends PetMeds’ direct-to-consumer reach into underserved rural markets, increasing potential customer base by millions.
Does Rallies summarize PETS news?
Yes. Rallies summarizes PETS news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is PETS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PETS. It does not provide personalized investment advice.
